AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 288: H759-H768, 2005. First published October 7, 2004; doi:10.1152/ajpheart.00786.2004
0363-6135/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/2/H759    most recent
00786.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lloyd, P. G.
Right arrow Articles by Terjung, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lloyd, P. G.
Right arrow Articles by Terjung, R. L.

VEGF receptor antagonism blocks arteriogenesis, but only partially inhibits angiogenesis, in skeletal muscle of exercise-trained rats

Pamela G. Lloyd,1 Barry M. Prior,1 Han Li,1 Hsiao T. Yang,1 and Ronald L. Terjung1,2,3

1Department of Biomedical Sciences, College of Veterinary Medicine, 2Department of Medical Pharmacology and Physiology, College of Medicine, and 3Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri

Submitted 3 August 2004 ; accepted in final form 4 October 2004

Both collateral vessel enlargement (arteriogenesis) and capillary growth (angiogenesis) in skeletal muscle occur in response to exercise training. Vascular endothelial growth factor (VEGF) is implicated in both processes. Thus we examined the effect of a VEGF receptor (VEGF-R) inhibitor (ZD4190, AstraZeneca) on collateral-dependent blood flow in vivo and collateral artery size ex vivo (indicators of arteriogenesis) and capillary contacts per fiber (CCF; an index of angiogenesis) in skeletal muscle of both sedentary and exercise-trained rats 14 days after bilateral occlusion of the femoral arteries. Total daily treadmill run time increased appreciably from ~70 to ~100 min (at 15–20 m/min, twice per day) and produced a large (~75%, P < 0.01) increase in calf muscle blood flow and a greater size of the collateral artery (wall cross-sectional area). ZD4190, which previously has been shown to inhibit the activity of VEGF-R2 and -R1 tyrosine kinase in vitro (IC50 = 30 and 700 nM, respectively), completely blocked the increase in collateral-dependent blood flow and inhibited collateral vessel enlargement. Thus exercise-stimulated collateral arteriogenesis appears to be completely dependent on VEGF-R signaling. Interestingly, enhanced mRNA expression of the VEGF family ligand placental growth factor (2- to 3.5-fold), VEGF-R1 (~2-fold), and endothelial nitric oxide synthase (2- to 3.5-fold) in an isolated collateral artery implicates these factors as important in arteriogenesis. Training of ischemic muscle also induced angiogenesis, as shown by an increase (~25%, P < 0.01) in CCF in white gastrocnemius muscle. VEGF-R inhibition only partially blocked (P < 0.01) but did not eliminate the increase (P < 0.01) in capillarity. Our findings indicate that VEGF-R tyrosine kinase activity is essential for collateral arteriogenesis and important for the angiogenesis induced in ischemic muscle by exercise training; however, other angiogenic stimuli are also important for angiogenesis in flow-limited active muscle.

kinase insert domain-containing receptor; Flt; receptor tyrosine kinase inhibition; treadmill running; vascular endothelial growth factor



Address for reprint requests and other correspondence: R. L. Terjung, Dept. of Biomedical Sciences, E102 Veterinary Medicine Bldg., 1600 E. Rollins Rd., Univ. of Missouri, Columbia, MO 65211 (E-mail: TerjungR{at}missouri.edu)




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
T. Gustafsson, H. Rundqvist, J. Norrbom, E. Rullman, E. Jansson, and C. J. Sundberg
The influence of physical training on the angiopoietin and VEGF-A systems in human skeletal muscle
J Appl Physiol, September 1, 2007; 103(3): 1012 - 1020.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
D. Chalothorn, J. A. Clayton, H. Zhang, D. Pomp, and J. E. Faber
Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains
Physiol Genomics, July 18, 2007; 30(2): 179 - 191.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. N. Carr, B. W. Howard, H. T. Yang, E. Eby-Wilkens, P. Loos, A. Varbanov, A. Qu, J. P. DeMuth, M. G. Davis, A. Proia, et al.
Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: Support for an endothelium-dependent mechanism
Cardiovasc Res, March 1, 2006; 69(4): 925 - 935.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
J. Suzuki
Microvascular angioadaptation after endurance training with L-arginine supplementation in rat heart and hindleg muscles
Exp Physiol, September 1, 2005; 90(5): 763 - 771.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
T. Gustafsson, H. Ameln, H. Fischer, C. J. Sundberg, J. A. Timmons, and E. Jansson
VEGF-A splice variants and related receptor expression in human skeletal muscle following submaximal exercise
J Appl Physiol, June 1, 2005; 98(6): 2137 - 2146.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.